According to WHO, five diseases are responsible for a preponderant share of morbidity and mortality in Africa: HIV, Tuberculosis, Malaria, Diabetes and Hypertension.
Any company based in Africa is concerned by these diseases, which are the leading causes of death and absenteeism, the main reason for seeing the doctor and the biggest source of medical expenses for employees and their families.
The example of malaria is emblematic in this respect. In fact, beyond the health crises and deaths it causes, malaria is an obstacle to economic development.
According to the World Bank, malaria causes the equivalent of 10€ billion in GDP on the African continent to be lost each year.
It is socially responsible and economically profitable for companies to invest in health. The cost of inaction is 3 to 4 times higher than the cost of action. It is estimated that the average cost attributable to malaria-related absenteeism and curative expenses is around 100€ per employee per year. This cost should be compared to the budget of 25€ per employee needed to raise awareness and equip each household with long-lasting insecticide-treated nets. The return on investment is quite significant: 1€ invested in prevention generates 4€ in savings.
Africa is the most HIV/AIDS affected region in the world, with predominance amongst young women.
The HIV/AIDS pandemic has an impact on labour supply, through increased mortality and morbidity.
People living with HIV in the Eastern and Southern Africa Region in 2017
People living with HIV in the West and Central Africa Region in 2017
$170 - $300
Annual costs per employee associated with sickness and reduced productivity
Reduction in growth rate due to reduced availability of skilled labour